Erratum: Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction (Cardiovascular Research (2014) 101 (97-107) DOI: 10.1093/cvr/cvt235);Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction

Cardiovascular Research

Volumn 101, Issue 1, 2014, Pages 97-107

  Unsöld, Bernhard ^a   Kaul, Axel ^a   Sbroggiò, Mauro ^b   Schubert, Carola ^c   Regitz Zagrosek, Vera ^c   Brancaccio, Mara ^b   Damilano, Federico ^b   Hirsch, Emilio ^b   Van Bilsen, Marc ^d   Munts, Chantal ^d   Sipido, Karin ^e   Bito, Virginie ^e   Detre, Elke ^e   Wagner, Nana Maria ^a   Schäfer, Katrin ^a   Seidler, Tim ^a   Vogt, Johannes ^a   Neef, Stefan ^a   Bleckmann, Annalen ^f   Maier, Lars S ^a   Balligand, Jean Luc ^g   Bouzin, Caroline ^g   Ventura Clapier, Renée ^h   Garnier, Anne ^h   Eschenhagen, Thomas ⁱ   El Armouche, Ali ^a   Knöll, Ralph ^j   Tarone, Guido ^b   Hasenfuß, Gerd ^a   more..

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF TURIN   (Italy)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^h Universite Paris Sud   (France)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Chaperon; Infarction; Map kinase; Remodelling; Transgenic animal models

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 70; MELUSIN; MITOGEN ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEART DILATATION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART RUPTURE; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

CHAPERON; INFARCTION; MAP KINASE; REMODELLING; TRANSGENIC ANIMAL MODELS;

ANIMALS; APOPTOSIS; COLLAGEN; CYTOSKELETAL PROTEINS; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HEART RUPTURE; HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; VENTRICULAR REMODELING;

EID: 84891359511     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvaa038     Document Type: Erratum

References (45)

1. Brancaccio M, Guazzone S, Menini N, Sibona E, Hirsch E, De AndreaMet al. Melusin is a newmuscle-specific interactor for beta(1) integrin cytoplasmic domain. J Biol Chem 1999; 274:29282-29288.
2. Brancaccio M, Fratta L, Notte A, Hirsch E, Poulet R, Guazzone S et al. Melusin, amusclespecific integrin beta1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat Med 2003;9:68-75.
3. Sbroggio M, Ferretti R, Percivalle E, Gutkowska M, Zylicz A, Michowski W et al. The mammalianCHORD-containing protein melusin is a stress response protein interacting with Hsp90 and Sgt1. FEBS Lett 2008;582:1788-1794.
4. De Acetis M, Notte A, Accornero F, Selvetella G, Brancaccio M, Vecchione C et al. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to longstanding pressure overload. Circ Res 2005;96:1087-1094.
5. Sbroggio M, Bertero A, Velasco S, Fusella F, De Blasio E, BahouWF et al. ERK1/2 Activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1. J Cell Sci 2011;124:3515-3524.
6. Ferretti R, Sbroggio M, Di Savino A, Fusella F, Bertero A, MichowskiWet al. Morgana and melusin: two fairies chaperoning signal transduction. Cell Cycle 2011;10:3678-3683.
7. Purcell NH, Wilkins BJ, York A, Saba-El-Leil MK, Meloche S, Robbins J et al. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc Natl Acad Sci USA 2007;104:14074-14079.
8. Brokat S, Thomas J, Herda LR, Knosalla C, Pregla R, Brancaccio M et al. Altered melusin expression in the hearts of aortic stenosis patients. Eur J Heart Fail 2007;9:568-573.
9. Tiyyagura SR, Pinney SP. Left ventricular remodelling after myocardial infarction: past, present and future. Mt Sinai J Med 2006;73:840-851.
10. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in cardiology 4: controversies in ventricular remodelling. Lancet 2006;367:356-367.
11. Pfeffer MA, Braunwald E. Ventricular remodelling after myocardial-infarction: experimental-observations and clinical implications. Circulation 1990;81:1161-1172.
12. Willis MS, Patterson C. Holdmetight: role of the heat shock protein family of chaperones in cardiac disease. Circulation 2010;122:1740-1751.
13. Yeh CC, Malhotra D, Yang YL, Xu Y, Fan Y, LiHet al. MEK1-induced Physiological hypertrophy inhibits chronic post-myocardial infarction remodelling in mice. J Cell Biochem 2013;114:47-55.
14. Mork HK, Sjaastad I, Sejersted OM, Louch WE. Slowing of cardiomyocyte Ca2+ release and contraction during heart failure progression in postinfarction mice. AmJ Physiol Heart Circ Physiol 2009;296:H1069-H1079.
15. Mork HK, Sjaastad I, Sande JB, Periasamy M, Sejersted OM, Louch WE. Increased cardiomyocyte function and Ca2+transients in mice during early congestive heart failure. J Mol Cell Cardiol 2007;43:177-186.
16. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res 2012;110:159-173.
17. Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res 2005;66:22-32.
18. Carnevale D, Cifelli G, Mascio G, Madonna M, Sbroggio M, Perrino C et al. Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-alpha-converting enzyme axis: crucial role for adaptive cardiac remodelling during cardiac pressure overload. Circulation 2011;124:1337-1350.
19. Iwasaki H, Kawamoto A, Tjwa M, Horii M, Hayashi S, OyamadaAet al. PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors. PLoS One 2011;6:e24872.
20. Frangogiannis NG. Matricellular proteins in cardiac adaptation and disease. Physiol Rev 2012;92:635-688.
21. Schellings MW, Pinto YM, Heymans S. Matricellular proteins in the heart: possible role during stress and remodelling. Cardiovasc Res 2004;64:24-31.
22. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodelling after infarction: the role of myofibroblasts. Nat Rev Cardiol 2010;7:30-37.
23. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996;94:2837-2842.
24. Natarajan M, Lin KM, Hsueh RC, Sternweis PC, Ranganathan R. Aglobal analysis of crosstalk in a mammalian cellular signalling network. Nat Cell Biol 2006;8:571-580.
25. Nair SC, Toran EJ, Rimerman RA, Hjermstad S, Smithgall TE, Smith DF. A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1, and the aryl hydrocarbon receptor. Cell Stress Chaperones 1996;1:237-250.
26. Meimaridou E, Gooljar SB, Chapple JP. From hatching to dispatching: the multiple cellular roles of the Hsp70 molecular chaperone machinery. J Mol Endocrinol 2009;42:1-9.
27. Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature 2011;475:324-332.
28. Latchman DS. Heat shock proteins and cardiac protection. Cardiovasc Res 2001;51: 637-646.
29. Jones Q, Voegeli TS, Li G, Chen Y, Currie RW. Heat shock proteins protect against ischemia and inflammation through multiple mechanisms. Inflamm Allergy Drug Targets 2011;10:247-259.
30. Borges TJ, Wieten L, van Herwijnen MJ, Broere F, van der Zee R, Bonorino C et al. The anti-inflammatory mechanisms of Hsp70. Front Immunol 2012;3:95.
31. Ortega E, Bote ME, Besedovsky HO, del Rey A. Hsp72, inflammation, and aging: causes, consequences, and perspectives. Ann N Y Acad Sci 2012;1261:64-71.
32. Chatterjee M, Andrulis M, Stuhmer T, Muller E, Hofmann C, Steinbrunn Tet al. The PI3K/Akt signalling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma. Haematologica 2013;98:1132-1141.
33. Gu R, Zheng D, Bai J, Xie J, Dai Q, Xu B. Altered melusin pathways involved in cardiac remodelling following acute myocardial infarction. Cardiovasc Pathol 2012;21:105-111.
34. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006;7:589-600.
35. Gao XM, White DA, Dart AM, Du XJ. Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions. Pharmacol Ther 2012;134:156-179.
36. Nahrendorf M, Swirski FK. Monocyte and macrophage heterogeneity in the heart. Circ Res 2013;112:1624-1633.
37. Lee EY, Lee ZH, Song YW. CXCL10 and autoimmune diseases. Autoimmun Rev 2009;8: 379-383.
38. Iwama H,Uemura S, NayaN, ImagawaK, Takemoto Y, AsaiOet al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol 2006;47:1559-1567.
39. Okamoto H, Imanaka-Yoshida K. Matricellular proteins: new molecular targets to prevent heart failure. Cardiovasc Ther 2012;30:e198-e209.
40. OkaT,XuJ, Kaiser RA, Melendez J, Hambleton M, SargentMAet al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodelling. Circ Res 2007;101:313-321.
41. Shimazaki M, Nakamura K, Kii I, KashimaT, Amizuka N, LiMet al. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 2008;205:295-303.
42. SchellingsMW, Vanhoutte D, Swinnen M, Cleutjens JP, Debets J, van Leeuwen RE et al. Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med 2009;206:113-123.
43. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L et al. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 2001;88:1080-1087.
44. FrangogiannisNG,RenG,Dewald O,ZymekP, Haudek S, KoertingAet al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005;111:2935-2942.
45. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M et al. Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 2005;167:71-80.